Doxorubicin Hydrochloride Injection 50 mg/ml
Pack of 10 Ampoules
Doxorubicin Injection is used in the treatment of various types of cancers. It is commonly prescribed as part of chemotherapy regimens to slow or stop the growth of cancer cells. The injection is widely used in oncology for its effectiveness against a broad range of malignancies.
Doxorubicin Hydrochloride Injection is a cytotoxic chemotherapy medication belonging to the anthracycline class of anticancer agents. It is widely used in oncology for the treatment of a variety of cancers, either alone or in combination with other chemotherapeutic drugs. Doxorubicin works by inhibiting the growth and spread of cancer cells, making it an essential component in cancer treatment protocols.
This injectable formulation is administered in clinical settings under strict medical supervision and is known for its broad-spectrum anticancer activity. Manufactured under stringent quality standards, the product ensures safety, sterility, and consistent efficacy. It is suitable for hospitals, oncology centers, and pharmaceutical distributors seeking reliable and export-quality oncology products.
Anticancer / Chemotherapy Agent (Anthracycline)
Injection
Doxorubicin is an anthracycline antibiotic that works by intercalating into DNA and inhibiting topoisomerase II, an enzyme essential for DNA replication. It also generates free radicals that damage cellular components, leading to cancer cell death. This dual action disrupts the growth and division of rapidly multiplying cancer cells.
Doxorubicin Injection should be administered only by qualified healthcare professionals in specialized oncology settings. The dosage and frequency depend on the patient’s condition, body surface area, and treatment protocol. It is usually given intravenously. Strict adherence to prescribed dosage is essential to minimize the risk of toxicity.
Use under strict medical supervision. Doxorubicin may cause cardiotoxicity, so monitoring of heart function is recommended during treatment. Caution is advised in patients with liver impairment or pre-existing cardiac conditions. Avoid self-medication and follow prescribed chemotherapy protocols. Prevent duplication with other anthracycline drugs.
Doxorubicin may interact with other cytotoxic drugs, immunosuppressants, and cardiotoxic agents, increasing the risk of adverse effects. Concurrent use with other chemotherapy agents should be carefully monitored by healthcare professionals.
Pregnancy: Consult doctor before use
Breastfeeding: Consult doctor before use
Store in a cool, dry place below 25°C, away from sunlight and moisture. Keep out of reach of children.
24 months
This product is manufactured in a WHO-GMP compliant facility following strict quality assurance protocols. Each batch undergoes rigorous testing for sterility, potency, and safety. The product is suitable for export markets with complete regulatory documentation support.
Allotab Healthcare is a leading pharmaceutical manufacturer and exporter operating from a WHO-GMP and EU-GMP certified facility in India, ensuring the highest standards of quality and compliance. We offer a wide range of pharmaceutical formulations including tablets, capsules, injections, ointments, oral liquids, and advanced molecules, catering to diverse therapeutic segments. Our portfolio also includes a comprehensive range of oncology products, supporting global healthcare needs. With strong manufacturing capabilities, regulatory expertise, and reliable supply, Allotab Healthcare serves distributors, hospitals, and healthcare organizations across international markets.
We offer a reliable bulk supply of oncology products including Doxorubicin Injection. Our services include export support, competitive pricing, and custom packaging solutions tailored to global market requirements.
This information is for informational purposes only. Use under medical supervision.